The AI Companion Use Risk Assessment (ACURA) is a clinician-administered or clinician-supervised screening instrument designed to assess co-occurring patterns of compulsive or problematic AI use across seven clinical domains. It is appropriate for adults 18+ and is grounded in current behavioral addiction research.
Primary research includes Chu, M.D., Gerard, P., Pawar, K., Bickham, C., & Lerman, K. (2025). Illusions of Intimacy: Emotional Attachment and Emerging Psychological Risks in Human-AI Relationships. USC Information Sciences Institute / AAAI.
Additional theoretical grounding draws on Bowlby’s attachment theory, Suler’s online disinhibition effect, and behavioral addiction frameworks consistent with Patrick Carnes’ CSAT model.
IMPORTANT DISCLAIMER
The ACURA is not a diagnostic tool. It is a screening instrument and has not undergone formal psychometric validation, including reliability testing, factor analysis, or normative standardization. This instrument was developed in response to emerging empirical literature on human-AI emotional dynamics for use by Debra Kaplan, MA, LPC, CSAT-S with AI assistance developed by Anthropic (claude.ai).
The ACURA has not been subjected to peer review, published in a clinical or scientific journal, or independently validat ed by external researchers. The item content, subscale structure, and scoring thresholds were derived from the clinician’s professional judgment informed by published empirical literature. This instrument is intended solely as a clinical conversation starter and structured observation aid.
*** The ACURA is intended for informational purposes only and is not a diagnostic tool. Results and clinical interpretation are provided exclusively by Debra Kaplan, MA, LPC, CSAT-S. To obtain results or to discuss next steps, please contact Debra Kaplan directly at debrakaplancounseling.com/contact. Individuals taking the assessment should first consider individual history and pre-existing conditions. It is recommended to seek support if elevated scores warrant deeper clinical exploration.
The AI Companion Use Risk Assessment (ACURA) is a clinician-developed screening instrument and has not undergone formal psychometric validation, including reliability testing, factor analysis, or normative standardization. It has not been subjected to peer review, published in a clinical or scientific journal, or independently validated by external researchers. The item content, subscale structure, and scoring thresholds were derived from the clinician’s professional judgment informed by published empirical literature on human-AI interaction — they do not constitute a validated psychometric scale in the formal sense.
This instrument is intended solely as a clinical conversation starter and structured observation aid. It should not be used to render diagnoses, make treatment determinations, or support legal or forensic conclusions as a standalone instrument. Scores must be interpreted within the full clinical context, including the client’s history, presenting concerns, cultural background, and the therapeutic relationship. Clinicians are responsible for the appropriate and ethical use of this tool within the scope of their licensure and professional standards.
This instrument was developed with the assistance of Claude, an artificial intelligence system produced by Anthropic (claude.ai). The AI was used to generate item language, organize subscale structure, and format the document based on directions and clinical parameters provided by the clinician. All clinical content was reviewed, directed, and approved by the named clinician; the use of AI in development does not imply AI authorship or independent clinical judgment on the part of the AI system.
Clinicians who adapt, distribute, or publish this tool are advised to disclose its AI-assisted development origins in accordance with applicable professional ethics codes, including those issued by ACA, NASW, AAMFT, or governing licensing boards. The clinical and ethical responsibility for use of this instrument rests solely with the administering clinician.
This instrument was developed in response to emerging empirical literature on human-AI emotional dynamics. Primary research basis includes:
Additional theoretical grounding draws on Bowlby’s attachment theory, Suler’s online disinhibition effect, and behavioral addiction frameworks consistent with Patrick Carnes’ CSAT model.
The ACURA has been sent successfully. Debra Kaplan will receive the completed assessment for clinical review.